NCT05848011 2026-04-17A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate CancerMacroGenicsPhase 2 Completed154 enrolled
NCT04381832 2025-07-22Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate CancerArcus Biosciences, Inc.Phase 1/2 Completed173 enrolled